Cargando…

Centrality of Early Synaptopathy in Parkinson’s Disease

Significant advances have been made in the understanding of the numerous mechanisms involved in Parkinson’s disease (PD) pathogenesis. The identification of PD pathogenic mutations and the use of different animal models have contributed to better elucidate the processes underlying the disease. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Imbriani, Paola, Schirinzi, Tommaso, Meringolo, Maria, Mercuri, Nicola B., Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837972/
https://www.ncbi.nlm.nih.gov/pubmed/29545770
http://dx.doi.org/10.3389/fneur.2018.00103
_version_ 1783304153021284352
author Imbriani, Paola
Schirinzi, Tommaso
Meringolo, Maria
Mercuri, Nicola B.
Pisani, Antonio
author_facet Imbriani, Paola
Schirinzi, Tommaso
Meringolo, Maria
Mercuri, Nicola B.
Pisani, Antonio
author_sort Imbriani, Paola
collection PubMed
description Significant advances have been made in the understanding of the numerous mechanisms involved in Parkinson’s disease (PD) pathogenesis. The identification of PD pathogenic mutations and the use of different animal models have contributed to better elucidate the processes underlying the disease. Here, we report a brief survey of some relevant cellular mechanisms, including autophagic–lysosomal dysfunction, endoplasmic reticulum stress, and mitochondrial impairment, with the main aim to focus on their potential convergent roles in determining early alterations at the synaptic level, mainly consisting in a decrease in dopamine release at nigrostriatal terminals and loss of synaptic plasticity at corticostriatal synapses. In a number of experimental models, this synaptopathy has been shown to be an initial, central event in PD pathogenesis, preceding neuronal damage, thereby representing a valuable tool for testing potential disease-modifying treatments.
format Online
Article
Text
id pubmed-5837972
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58379722018-03-15 Centrality of Early Synaptopathy in Parkinson’s Disease Imbriani, Paola Schirinzi, Tommaso Meringolo, Maria Mercuri, Nicola B. Pisani, Antonio Front Neurol Neuroscience Significant advances have been made in the understanding of the numerous mechanisms involved in Parkinson’s disease (PD) pathogenesis. The identification of PD pathogenic mutations and the use of different animal models have contributed to better elucidate the processes underlying the disease. Here, we report a brief survey of some relevant cellular mechanisms, including autophagic–lysosomal dysfunction, endoplasmic reticulum stress, and mitochondrial impairment, with the main aim to focus on their potential convergent roles in determining early alterations at the synaptic level, mainly consisting in a decrease in dopamine release at nigrostriatal terminals and loss of synaptic plasticity at corticostriatal synapses. In a number of experimental models, this synaptopathy has been shown to be an initial, central event in PD pathogenesis, preceding neuronal damage, thereby representing a valuable tool for testing potential disease-modifying treatments. Frontiers Media S.A. 2018-03-01 /pmc/articles/PMC5837972/ /pubmed/29545770 http://dx.doi.org/10.3389/fneur.2018.00103 Text en Copyright © 2018 Imbriani, Schirinzi, Meringolo, Mercuri and Pisani. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Imbriani, Paola
Schirinzi, Tommaso
Meringolo, Maria
Mercuri, Nicola B.
Pisani, Antonio
Centrality of Early Synaptopathy in Parkinson’s Disease
title Centrality of Early Synaptopathy in Parkinson’s Disease
title_full Centrality of Early Synaptopathy in Parkinson’s Disease
title_fullStr Centrality of Early Synaptopathy in Parkinson’s Disease
title_full_unstemmed Centrality of Early Synaptopathy in Parkinson’s Disease
title_short Centrality of Early Synaptopathy in Parkinson’s Disease
title_sort centrality of early synaptopathy in parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837972/
https://www.ncbi.nlm.nih.gov/pubmed/29545770
http://dx.doi.org/10.3389/fneur.2018.00103
work_keys_str_mv AT imbrianipaola centralityofearlysynaptopathyinparkinsonsdisease
AT schirinzitommaso centralityofearlysynaptopathyinparkinsonsdisease
AT meringolomaria centralityofearlysynaptopathyinparkinsonsdisease
AT mercurinicolab centralityofearlysynaptopathyinparkinsonsdisease
AT pisaniantonio centralityofearlysynaptopathyinparkinsonsdisease